Kingworld Medicines Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	293	307	270	392	529	473
Market Cap Growth	6.34%	13.61%	-31.19%	-25.88%	11.84%	1.33%
Enterprise Value	550	594	465	522	655	601
Last Close Price	0.49	0.52	0.43	0.56	0.74	0.62
PE Ratio	23.11	24.42	6.10	9.34	20.58	12.71
Forward PE	-	9.16	9.16	9.16	9.16	9.16
PS Ratio	0.29	0.30	0.24	0.33	0.49	0.46
PB Ratio	0.38	0.40	0.36	0.51	0.67	0.54
P/TBV Ratio	0.50	0.52	0.46	0.67	0.89	0.75
P/FCF Ratio	-	-	2.68	-	5.03	16.85
P/OCF Ratio	-	-	1.87	8.42	2.51	4.75
EV/Sales Ratio	0.54	0.58	0.41	0.44	0.61	0.58
EV/EBITDA Ratio	6.59	8.01	4.18	5.35	5.39	5.08
EV/EBIT Ratio	7.78	9.68	4.69	6.02	7.21	6.87
EV/FCF Ratio	-	-	4.61	-	6.22	21.40
Debt / Equity Ratio	0.63	0.63	0.57	0.51	0.42	0.33
Debt / EBITDA Ratio	6.51	6.51	3.55	3.59	2.45	2.25
Debt / FCF Ratio	-	-	4.25	-	3.12	10.44
Net Debt / Equity Ratio	0.23	0.23	0.22	0.23	0.05	0.06
Net Debt / EBITDA Ratio	2.39	2.39	1.46	1.81	0.32	0.42
Net Debt / FCF Ratio	-	-	1.61	-2.54	0.37	1.77
Asset Turnover	0.64	0.64	0.77	0.83	0.77	0.69
Inventory Turnover	5.28	5.28	6.65	7.89	7.10	4.93
Quick Ratio	0.76	0.76	0.87	0.92	0.90	1.00
Current Ratio	1.09	1.09	1.18	1.27	1.15	1.35
Return on Equity (ROE)	5.58%	5.58%	10.60%	8.84%	6.16%	7.32%
Return on Assets (ROA)	2.41%	2.41%	4.23%	3.78%	4.05%	3.61%
Return on Invested Capital (ROIC)	4.40%	4.38%	8.45%	6.50%	6.95%	7.08%
Return on Capital Employed (ROCE)	6.30%	6.30%	10.30%	9.00%	11.10%	9.60%
Earnings Yield	4.28%	4.09%	16.39%	10.70%	4.86%	7.87%
FCF Yield	-	-	37.36%	-17.77%	19.88%	5.94%
Dividend Yield	6.60%	-	7.36%	6.02%	3.35%	3.84%
Payout Ratio	-	-	47.60%	36.54%	58.45%	10.89%
Buyback Yield / Dilution	-1.78%	-1.78%	2.66%	2.49%	-0.04%	1.29%
Total Shareholder Return	4.83%	-1.78%	10.02%	8.51%	3.32%	5.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.